Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
AIT drops
DRUG
2 trials
Sponsors
Beijing Tongren Hospital
Conditions
Allergic Rhinitis
Phase 3
Safety and Efficacy of Sublingual Immunotherapy for Allergic Rhinitis Due to Artemisia Annua
Completed
NCT03990272
Beijing Tongren Hospital
Allergic Rhinitis
Start: 2017-03-20
End: 2017-10-30
Updated: 2020-07-16
Phase 4
Efficacy of Artemisia Pollen Specific Allergen Immunotherapy
NCT05318157
Beijing Tongren Hospital
Allergic Rhinitis
Start: 2022-03-31
End: 2024-11-30
Target: 150
Updated: 2022-05-26